Is an adrenal adenoma malignant?

Is an Adrenal Adenoma Malignant?

No, an adrenal adenoma is by definition a benign tumor and is not malignant. However, distinguishing a true adenoma from malignant lesions (adrenocortical carcinoma or metastases) requires careful evaluation, as imaging and even initial pathology can sometimes be misleading.

Understanding the Distinction

The vast majority (71-84%) of adrenal incidentalomas are benign, non-functioning adenomas 1. The key challenge in clinical practice is differentiating benign adenomas from the 1.2-12% that are adrenocortical carcinomas (ACC) or the 0-21% that are metastases 1.

Critical Evaluation Points

When you encounter an adrenal mass, you must systematically exclude malignancy through:

Imaging characteristics:

• Density on non-contrast CT < 10 Hounsfield Units (HU) is diagnostic of a lipid-rich adenoma and requires no further imaging workup 2
• Lesions with density 10-20 HU warrant additional characterization with washout CT or chemical shift MRI 1
• Lesions > 20 HU, even if < 4 cm, should be discussed at multidisciplinary conference given higher malignancy risk 2

Size matters significantly:

• Lesions < 4 cm have ~7% malignancy risk
• Lesions 4-6 cm have 6% malignancy risk
• Lesions > 6 cm have > 25% malignancy risk 2

Important Caveats and Pitfalls

Washout CT has significant limitations that you must understand 1:

• Approximately 1/3 of pheochromocytomas can washout in the adenoma range
• Approximately 1/3 of true adenomas do NOT washout in the adenoma range
• Some malignant masses (ACC, hypervascular metastases) can washout in the adenoma range

This means a "benign-appearing" washout does not guarantee benignity, particularly in younger patients or larger lesions 3.

The Rare Adenoma-to-Carcinoma Phenomenon

While extremely uncommon, recent case reports document ACC developing from lesions with initially benign radiological features 4, 5, 6. These cases showed:

• Prolonged stability (up to 14 years) before rapid growth 6
• Initial pathology interpreted as adenoma, later proven to be ACC 4
• Lesions that met radiological criteria for adenoma at baseline 6

This adenoma-to-carcinoma transition appears possible but exceedingly rare 6. The estimated risk of a benign, non-functioning incidentaloma developing into malignancy is only 0.2% 2.

High-Risk Populations Requiring Heightened Vigilance

Patients < 40 years old:

• Higher risk of malignancy and hormone excess 2
• Should undergo urgent MRI assessment
• Consider surgical resection for any lesion not characteristically benign on imaging 2
• Even benign-appearing lesions warrant single follow-up at 12 months 2

Patients with extra-adrenal malignancy:

• < 30% of adrenal lesions are metastatic, but for indeterminate lesions, up to 70% are malignant 2
• Must still exclude pheochromocytoma before biopsy 2

Follow-Up Strategy for Indeterminate Lesions

If you choose surveillance over immediate resection:

Growth patterns suggesting malignancy:

• Growth ≥ 5 mm/year warrants repeat functional workup and consideration of adrenalectomy 1
• Growth ≥ 8 mm in 12 months requires further investigation 2
• Growth < 3 mm/year likely benign, no further imaging needed 1

Lesions stable for ≥ 12 months can usually be considered benign 2, though the rare cases above demonstrate this is not absolute.

When to Biopsy (Rarely)

Adrenal biopsy should be reserved for:

• Patients with extra-adrenal malignancy AND indeterminate adrenal mass where histology would change management 2
• Never biopsy suspected ACC (risk of needle tract seeding) 1
• Always exclude pheochromocytoma biochemically before any biopsy 1, 2

Bottom Line

An adrenal adenoma is benign by definition. Your clinical challenge is ensuring the lesion truly is an adenoma through proper imaging characterization (density < 10 HU is definitive), size assessment, functional testing to exclude hormone excess, and appropriate surveillance or resection based on risk stratification. Be particularly cautious with lesions > 4 cm, density > 20 HU, patients < 40 years, and any lesion showing growth > 5 mm/year, as these warrant multidisciplinary discussion and often surgical resection 1, 2.